4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-000892
Chief Financial Officer sold 10,000 shares at an average $39.24 ($392,409)
- Chief Financial Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-01-02 | Option exercise 10b5-1 | +10,000 | $15.60 | $155,983 | 12,291 | D |
| Thunen Shelley B Chief Financial Officer | 2024-01-02 | Sale 10b5-1 | −4,519 | $38.77 | $175,191 | 7,772 | D |
| Thunen Shelley B Chief Financial Officer | 2024-01-02 | Sale 10b5-1 | −5,481 | $39.63 | $217,218 | 2,291 | D |
| Derivatives | |||||||
| Thunen Shelley B Chief Financial Officer | 2024-01-02 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 66,805 | D | ||
| Open-market sales · 10,000 sh · avg $39.24 · $392,409 | |||||||
Loading xslF345X05/ownership.xml…